Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-κB inhibition

Department of Bioscience, Clinical Research Center, Karolinska Institutet, Novum, SE-141 57 Huddinge, Sweden.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 05/2004; 101(14):4972-7. DOI: 10.1073/pnas.0307106101

ABSTRACT NF-kappaB signaling plays an important role in skin development and epidermal growth control. Moreover, inhibition of NF-kappaB signaling in murine epidermal keratinocytes in vivo, by expression of a keratin 5 (K5)-directed superrepressor form of inhibitor of NF-kappaB (IkappaBalpha), results in an inflammatory response characterized by a massive dermal infiltration of neutrophils, epidermal hyperplasia, and a rapid development of aneuploid squamous cell carcinomas (SCC). We now show that by crossing K5-IkappaBalpha mice onto a tumor necrosis factor receptor 1(Tnfr1)-null background, both the inflammatory and the tumorigenic responses are blocked. The specificity of the block is illustrated by the fact that K5-IkappaBalpha mice lacking the IL-1 receptor type 1 (Il1r1) develop inflammation and squamous cell carcinomas. Reconstitution of lethally irradiated K5-IkappaBalpha/Tnfr1(-/-) mice with Tnfr1(+/-) bone-marrow does not induce the inflammatory or the tumorigenic phenotype, indicating a critical dependence on Tnfr1-mediated signaling in skin cells or nonimmune cells. Our results suggest a critical role of local Tnfr1-mediated signaling and associated inflammatory response cooperating with repressed keratinocyte NF-kappaB signaling in driving skin cancer development.

Download full-text


Available from: Rune Toftgård, Aug 01, 2015
1 Follower
  • Source
    • "They consist of widespread scaly plaques, which upon histological analysis show acanthosis, hyperkeratosis, dilation of dermal blood vessels, and infiltration by a mixed inflammatory infiltrate with neutrophils forming aggregates in the upper epidermis (Pasparakis et al., 2002; van Hogerlinden et al., 1999). Genetic ablation of TNFR1 in the whole body prevents the development of inflammatory skin lesions in both the K14- Cre Ikk2 fl/fl and the K5-IkBaSR mice (Lind et al., 2004; Pasparakis et al., 2002), demonstrating that TNF regulates the pathogenesis of skin inflammation in these models similarly to psoriasis in humans. Skin inflammation in K14-Cre Ikk2 fl/fl mice occurs independently of ab T cells but requires the presence of macrophages in the dermis (Stratis et al., 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Psoriasis is a common chronic inflammatory skin disease with a prevalence of about 2% in the Caucasian population. Tumor necrosis factor (TNF) plays an essential role in the pathogenesis of psoriasis, but its mechanism of action remains poorly understood. Here we report that the development of psoriasis-like skin inflammation in mice with epidermis-specific inhibition of the transcription factor NF-κB was triggered by TNF receptor 1 (TNFR1)-dependent upregulation of interleukin-24 (IL-24) and activation of signal transducer and activator of transcription 3 (STAT3) signaling in keratinocytes. IL-24 was strongly expressed in human psoriatic epidermis, and pharmacological inhibition of NF-κB increased IL-24 expression in TNF-stimulated human primary keratinocytes, suggesting that this mechanism is relevant for human psoriasis. Therefore, our results expand current views on psoriasis pathogenesis by revealing a new keratinocyte-intrinsic mechanism that links TNFR1, NF-κB, ERK, IL-24, IL-22R1, and STAT3 signaling to disease initiation.
    Immunity 11/2013; 39. DOI:10.1016/j.immuni.2013.10.009 · 19.75 Impact Factor
  • Source
    • "Knocking out IKKa results in a severe cutaneous phenotype characterized by incomplete epidermal differentiation [4] and mice with an epidermis-specific deletion of IKK-b develop a severe inflammatory skin disease caused by a TNFa-mediated, ab T cell-independent inflammatory response that develops shortly after birth [5]. Conversely, over-expression of IjB results in hyperplasia and inflammation, and leads to squamous cell carcinomas [6]. The NFjB family includes the p65, p50 and c/rel proteins, which can homodimerize and heterodimerize among themselves [7]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: S100A8/A9 promotes NADPH oxidase in HaCaT keratinocytes and subsequently increases NFκB activation, which plays important roles in the balance between epidermal growth and differentiation. S100A8/A9-positive HaCaT cells present with a significantly reduced rate of cell division and greater expression of two keratinocyte differentiation markers, involucrin and filaggrin, than control cells. S100A8/A9 mutants fail to enhance NFκB activation, TNFα-induced IL-8 gene expression and NFκB p65 phosphorylation, and S100A8/A9-positive cells demonstrate better cell survival in forced suspension culture than mutant cells. S100A8/A9 is induced in epithelial cells in response to stress. Therefore, S100A8/A9-mediated growth arrest could have implications for tissue remodeling and repair.
    FEBS letters 01/2011; 585(2):440-6. DOI:10.1016/j.febslet.2010.12.037 · 3.34 Impact Factor
  • Source
    • "Although later studies showed that ibα knockout fibroblasts are not transformed [78] [79], the tumor suppressive role of IBα cannot be overlooked, as defective activity of IBα is often associated with persis- J Cancer Res 2011;1(2):192-221 tent NF-B activation in many human tumors. Importantly, overexpression of a superrepressor form of IBα induces tumor cell apoptosis and inhibits tumorigenesis in numerous animal models [48] [80] [81] [82]. In most cases, the I Bα deficiency in tumors is because of the enhanced protein degradation mediated by constitutively activated IKK. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent studies have clearly linked nuclear factor-kappaB (NF-κB), a transcription factor that plays a central role in regulating immune and inflammatory responses, to tumor development, progression, and metastasis as well as tumor therapy resistance. However, it still remains largely unknown on how the tightly regulated NF-κB becomes constitutively activated in tumorigenesis and how the original cancer immunosurveillance function of NF-κB is transformed to be tumorigenic. To address these important issues for cancer prevention and treatment, we discuss current understanding of the molecular mechanisms and molecules involved in the oncogenic activation of NF-κB. We also discuss current understanding of how NF-κB coordinates the inflammatory and malignant cells in tumorigenesis.
    American Journal of Cancer Research 01/2011; 1(2):192-221. · 3.97 Impact Factor
Show more